Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Benjamin Cuiffo"'
Autor:
Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Ramdane Guemiri, Andrew Boone, Deborah Bellet, Brianna Rivest, James Cardia, Caroline Robert, Simon P. Fricker
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveImmunotherapeutic inhibition of PD-1 by systemically administered monoclonal antibodies is widely used in cancer treatment, but it may cause severe immune-related adverse events (irSAEs). Neoadjuvant PD-1 inhibition before surgery has shown
Externí odkaz:
https://doaj.org/article/4c11e064c3e94d87ae9030c00767206b
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/df3f03f851424097b9b6f793b7d521f0
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/727d8d5895e94cad9f5a15fe468bc72c
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/a1509510cbd24ae0a228ff4698452082
Autor:
Shenghua Zhou, Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Brianna Rivest, Andrew Boone, James Cardia, Simon Fricker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::676526f6ce24306291102d6975ad8fe0
https://doi.org/10.1136/jitc-2022-sitc2022.1402
https://doi.org/10.1136/jitc-2022-sitc2022.1402
Autor:
Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Brianna Rivest, Andrew Boone, Shenghua Zhou, James Cardia, Simon Fricker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8e0a51e19165e6ddb547b4535be57c9
https://doi.org/10.1136/jitc-2022-sitc2022.0537
https://doi.org/10.1136/jitc-2022-sitc2022.0537
Autor:
Melissa Maxwell, Dingxue Yan, Brianna Rivest, Andrew Boone, Shenghua Zhou, Benjamin Cuiffo, James Cardia, Simon Fricker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aafd6f258f4495cafcb2c1e9343c9c98
https://doi.org/10.1136/jitc-2022-sitc2022.0493
https://doi.org/10.1136/jitc-2022-sitc2022.0493
Autor:
Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Andrew Boone, Brianna Rivest, Shenghua Zhou, James Cardia, Simon Fricker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::472b25b3b2bec042187afc6c325abf8d
https://doi.org/10.1136/jitc-2022-sitc2022.1431
https://doi.org/10.1136/jitc-2022-sitc2022.1431
Autor:
Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Shenghua Zhou, Brianna Rivest, Andrew Boone, James Cardia, Simon P. Fricker
Publikováno v:
Cancer Research. 82:4237-4237
Immune checkpoint inhibitor (ICI) anti-PD-1 antibody (mAb) monotherapy represented a significant advancement in cancer treatment, however most patients will ultimately progress, signaling the need for improvement. Combination approaches with other IC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01d853985e56a13e78e98bcc368ca7d6
https://doi.org/10.1158/1538-7445.am2022-4237
https://doi.org/10.1158/1538-7445.am2022-4237
Publikováno v:
Journal of Clinical Oncology. 40:TPS9608-TPS9608
TPS9608 Background: Antibodies targeting immune checkpoints such as PD-1 and CTLA-4 has shown significant benefit in late-stage melanoma. But further improvements in therapeutic options are still required. Two approaches for improving the outcome of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::015da02736fba6ee8b9d2d3518ce1057
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9608
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9608